icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
HIGH EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR (EBR/GZR) TREATMENT IN PATIENTS WITH HCV GENOTYPE 1A (GT1A) INFECTION IN GERMAN REAL-WORLD: RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
 
 
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna
 
Holger Hinrichsen1, Albrecht Stoehr2, Markus Cornberg3, Hartwig Klinker4, Renate Heyne5, Christine John6, Karl-Georg Simon7, Manfred Bilzer8, Veronika Guenther9, Karen Martin9, Vanessa Witte9, Stefan Zeuzem10
1Gastroenterology-Hepatology Center Kiel, Kiel; 2ifi - Institute for Interdisciplinary Medicine, Study Centre St. Georg, Hamburg; 3Hannover Medical School, Hannover; 4University Hospital Wurzburg, Wurzburg; 5Leberzentrum am Checkpoint, Berlin; 6Private Practice of Internal Medicine, Berlin; 7MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen; 8Bilzer Consulting, Munich; 9MSD Sharp & Dohme GmbH, Haar; 10Johann Wolfgang Goethe University, Frankfurt

0415191

0415192

0415193

0415194

0415195

0415196